299 related articles for article (PubMed ID: 28667294)
21. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
[TBL] [Abstract][Full Text] [Related]
22. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
23. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
[TBL] [Abstract][Full Text] [Related]
24. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
25. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
27. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
Jiang G; Wen L; Zheng H; Jian Z; Deng W
Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
29. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
[TBL] [Abstract][Full Text] [Related]
31. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
[TBL] [Abstract][Full Text] [Related]
32. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
33. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
34. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
[TBL] [Abstract][Full Text] [Related]
35. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
36. miR-34a repression of SIRT1 regulates apoptosis.
Yamakuchi M; Ferlito M; Lowenstein CJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13421-6. PubMed ID: 18755897
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.
Luo J; Chen P; Xie W; Wu F
Oncol Rep; 2017 Aug; 38(2):1067-1074. PubMed ID: 28677784
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
39. MiR-34, SIRT1 and p53: the feedback loop.
Yamakuchi M; Lowenstein CJ
Cell Cycle; 2009 Mar; 8(5):712-5. PubMed ID: 19221490
[TBL] [Abstract][Full Text] [Related]
40. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C
Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
